JACC: Cardiooncology

Papers
(The H4-Index of JACC: Cardiooncology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Full Issue PDF194
Priorities in Cardio-Oncology176
Atrial Fibrillation in Patients With Cancer133
Full Issue PDF116
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy105
Full Issue PDF104
Epigenomics of Cardio-Oncology101
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque87
Hormonal Therapy and Cardiovascular Health77
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors76
Balancing Promise and Evidence75
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy74
Cardiovascular Safety in Oncology Clinical Trials69
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes66
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients63
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part62
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors60
Full Issue PDF57
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD55
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy54
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients52
Cardiac Risk Stratification Before Lung Cancer Radiation51
Frailty49
Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis46
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma45
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy45
Risk Prediction in Cardio-Oncology: Conceptual and Methodological Considerations42
Proactive Surveillance for ICI Cardiotoxicity41
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)41
Incretin Mimetics in Cancer and Cardiovascular Disease41
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms41
Editorial Board/Officers Page40
Full Issue PDF39
Peripheral Ischemia Fuels Breast Cancer Via Myeloid-Skewed Hematopoiesis39
Atrial Fibrillation After Stem Cell Transplantation39
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD39
Cancer Immunotherapy Beyond Checkpoint Blockade39
Changes in Physical Activity and Cardiovascular Disease Risk in Cancer Survivors38
0.16126894950867